Effect of pharmacogenomics testing guiding on clinical outcomes in major depressive disorder: a systematic review and meta-analysis of RCT

BACKGROUND: Pharmacogenomic testing guided treatment have been developed to guide drug selection or conversion in major depressive disorder patients. Whether patients benefit from pharmacogenetic testing remains unclear. We aim to evaluates the effect of pharmacogenomic testing guiding on clinical o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xinrui, Wang, Chenfei, Zhang, Yi, An, Zhuoling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176803/
https://www.ncbi.nlm.nih.gov/pubmed/37173736
http://dx.doi.org/10.1186/s12888-023-04756-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176803/
https://www.ncbi.nlm.nih.gov/pubmed/37173736
http://dx.doi.org/10.1186/s12888-023-04756-2

Ejemplares similares